BRIEF-Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial
* Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial Source text for Eikon: Further company coverage: [Source]
Publication Date:Origin: reuters.com
Category: governmentFilingsNews
Topics: phase, treated, patient, first, announces, coverage, company, Further, Eikon, trial Source, 1/2 proclaim-072, Cytomx, trial, proclaim-072, BRIEF-Cytomx
Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/A1TNO0GBXrw/idUSASB0AY88